(Q45248637)

11 December 2017

Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis (English)

1 reference

11 December 2017

0 references

7

1 reference

11 December 2017

9

1 reference

11 December 2017

Haichao Wang

12

0 references

Mahendar Ochani

5

object named as

Mahendar Ochani

1 reference

11 December 2017

4

Christopher J Czura

1 reference

11 December 2017

6

Kanta Ochani

1 reference

11 December 2017

11

Andrew E Sama

1 reference

11 December 2017

3

Xiaoling Qiang

1 reference

11 December 2017

Guoqian Chen

1

1 reference

11 December 2017

Jianhua Li

2

1 reference

11 December 2017

Huan Yang

8

1 reference

11 December 2017

Ping Wang

10

1 reference

11 December 2017

1 February 2005

1 reference

Journal of Lipid Research

11 December 2017

1 reference

11 December 2017

46

1 reference

11 December 2017

4

1 reference

11 December 2017

623-627

1 reference

HMG-1 as a late mediator of endotoxin lethality in mice

11 December 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Specific recognition of cruciform DNA by nuclear protein HMG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Extracellular role of HMGB1 in inflammation and sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Therapeutic effects of lysophosphatidylcholine in experimental sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

Lipid unites disparate syndromes of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.C400018-JLR200

10.1194/JLR.C400018-JLR200

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference